We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$36.8M
Cap. Flow
-$46.8M
Cap. Flow %
-21.63%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$46.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$168M 77.6%
1,111,111
– –
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$2.52B
$48.5M 22.39%
3,846,154
– –
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$16K 0.01%
3,700
– –
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
– –
-2,575,450
Closed -$3.79M
EPZM
5
DELISTED
Epizyme, Inc
EPZM
– –
-31,841,394
Closed -$46.8M

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q3 2022 Portfolio in Review

As of Q3 2022, RP Management held 5 positions worth $216M, down 15% from $253M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RP Management withdrew a net $46.8M in Q3 2022, closing 2 positions. Its most notable exit was Epizyme, Inc, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • RP Management fully exited Epizyme, Inc in Q3 2022, selling an estimated $46.8M.
  • RP Management's ten largest holdings make up 100% of its $216M portfolio in Q3 2022.
  • RP Management opened 0 new positions and closed 2 in Q3 2022.
  • RP Management's portfolio value fell 15% quarter-over-quarter to $216M.

Based on RP Management's 13F filing for Q3 2022, filed 14 Nov 2022.